VAERS reports by lot

GSK Varicella/Shingles lot EE924: VAERS reports

33 VAERS reports list lot EE924 as a GSK Varicella/Shingles vaccine, received between 2019-10-16 and 2020-11-24. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
33
Reports
6%
Marked serious
0
With a death outcome
10
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
General / Systemic (non-local)2725%
Neurological1716%
Injection-site / Local reaction1514%
Dermatological (non-injection-site)1413%
Musculoskeletal1312%
Gastrointestinal98%
Allergic / Anaphylactic76%
Cardiac / Cardiovascular33%
Respiratory22%
Psychiatric / Neuropsychiatric11%

Where reports came from

U.S. state of the reporter, where given (top 12).

Michigan5
Connecticut4
Pennsylvania4
Georgia3
New York2
North Carolina2
Virginia2
Washington1
Tennessee1
Minnesota1
Alabama1
Ohio1

Reports by month received

2019-106
2019-1110
2019-125
2020-016
2020-021
2020-031
2020-051
2020-071
2020-081
2020-111

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.